Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study.
In recent years, low dose naltrexone (LDN) has been used as an off-label therapy for several chronic diseases. Results from small laboratory and clinical studies indicate some beneficial effects of LDN in autoimmune diseases, but clinical research on LDN in rheumatic disease is limited. Using a phar...
Main Authors: | Guttorm Raknes, Lars Småbrekke |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0212460 |
Similar Items
-
Correction: Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study.
by: Guttorm Raknes, et al.
Published: (2019-01-01) -
Low dose naltrexone in multiple sclerosis: Effects on medication use. A quasi-experimental study.
by: Guttorm Raknes, et al.
Published: (2017-01-01) -
No change in the consumption of thyroid hormones after starting low dose naltrexone (LDN): a quasi-experimental before-after study
by: Guttorm Raknes, et al.
Published: (2020-10-01) -
The Danish nationwide clinical register for patients with rheumatoid arthritis: DANBIO
by: Ibfelt EH, et al.
Published: (2016-10-01) -
Association between ischemic stroke and seropositive rheumatoid arthritis in Korea: A nationwide longitudinal cohort study.
by: Dong Hyun Lee, et al.
Published: (2021-01-01)